IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)

5.49% (1Y)

Market Cap	26.63B
Revenue (ttm)	20.79B
Net Income (ttm)	1.01B
Shares Out	n/a
EPS (ttm)	3.44
PE Ratio	26.35
Forward PE	19.92
Dividend	0.80 (0.87%)
Ex-Dividend Date	Feb 18, 2025

Volume	827,063
Average Volume	1,280,101
Open	91.20
Previous Close	90.67
Day's Range	90.65 - 92.93
52-Week Range	57.50 - 107.54
Beta	0.57
RSI	52.02
Earnings Date	Aug 11, 2025

About NSE:IOLCP

IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen lysinate and ibuprofen sodium; and other APIs, including metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole, gabapentin, levetiracetam, paracetamol, etc. Its active pharmaceutical ingredients are used for the treatment of anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1986
• Employees: 2,777
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: IOLCP

Financial Performance

In 2024, NSE:IOLCP's revenue was 20.79 billion, a decrease of -2.51% compared to the previous year's 21.33 billion. Earnings were 1.01 billion, a decrease of -24.82%.